- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Article
The Ethics of Pricing MD vs RN Treatments
Is it ethical to have a non-physician deliver laser/light treatment to patients at the same price? David Goldberg, M.D., J.D., and A. Jay Burns, M.D., call this topic into question at the Laser Roundtable during Vegas Cosmetic Surgery 2014.
Is it ethical to have a non-physician deliver laser/light treatment to patients at the same price? David Goldberg, M.D., J.D., and A. Jay Burns, M.D., call this topic into question at the Laser Roundtable during Vegas Cosmetic Surgery 2014.
Related Videos
Efficacy, Safety, and Role in Therapy of JAK Inhibitors for Atopic Dermatitis
The Impact of JAK Selectivity in Atopic Dermatitis Treatment
Recapping the Evolving Treatment Landscape for Atopic Dermatitis
Sunscreen Ingredients for UV and Visible Light Protection
The Solar Spectrum and Impact on Skin Health
Discussing Efficacy and Safety of JAK Inhibitors With Patients and Caregivers
Patient Considerations for Selecting Treatment for a 16-Year-Old Male With Severe Alopecia Areata
Future Directions for Pediatric Atopic Dermatitis Management and Research
New Systemic Therapies for Pediatric Atopic Dermatitis: Nemolizumab and Oral JAK Inhibitors
The JAK-STAT Signaling Pathway and Its Role in Atopic Dermatitis
Related Content
